Compare Cardinal Health Inc (CAH) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Prospect Capital Corporation — how do they compare? Cardinal Health Inc trades at $234.16 (market cap $55.88B), while Prospect Capital Corporation trades at $2.29 (market cap $1.14B). The key difference: Cardinal Health Inc is far larger — about 49× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (21.93%). Which is the better fit depends on your goals.
| CAH | PSEC | |
|---|---|---|
Market Cap | $55.88B | $1.14B |
Sector | Health | Financials |
52-Week High | $240.26 | $3.05 |
52-Week Low | $146.04 | $2.11 |
Enterprise Value | $59.91B | — |
Dividend Yield | 0.86% | 21.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $235.3, down 0.79% on the day, but remains near its 52-week high. The stock exhibits a bullish technical signal with consistent earnings beats in recent quarters, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue for fiscal 2025 was $222.58 billion, with net income reaching $1.56 billion. Analyst consensus is strongly positive, with 18 buys and a $266.43 price target, reflecting confidence in the company's pharmaceutical and specialty business growth.
The outlook for CAH is favorable, driven by robust earnings performance and optimistic fiscal 2027 guidance. Key opportunities include sustained demand for specialty drugs and operational efficiency gains. Risks involve high debt levels, with a debt-to-asset ratio of 16.09 in 2025, and competitive pressures in the healthcare distribution sector. Investors should weigh strong analyst support against balance sheet leverage and market volatility.
PSEC trades at $2.285, down 0.22% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company shows mixed fundamentals, with a low P/B of 0.39 and recent earnings beats, but negative revenue and net income margins. Recent news includes a dividend increase announcement and the sale of Valley Electric for $328 million, signaling active portfolio management.
Outlook: PSEC offers a deep value proposition with its discount to book value and high yield, but significant risks persist from negative profitability and volatile revenue trends. Analyst sentiment is cautious, with a majority hold rating, reflecting concerns over sustained earnings and NAV stability amid ongoing dividend adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
